Physician profile
Kelli Gosch
NPI 1558496414
$1,243.01
in general payments reported to CMS, 2019-2025
20 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $317 · 2023: $271 · 2024: $144 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.28 | 2021-2024 | |
| Organon LLC | $185.78 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $116.77 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $106.68 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $80.42 | 2021-2024 | |
| Hologic Sales and Service, LLC | $71.21 | 2023-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $56.47 | 2023 | Myrisk |
| Exeltis, USA INC. | $50.96 | 2024-2025 | Slynd |
| Pacira Pharmaceuticals Incorporated | $35.45 | 2025 | Exparel |
| Medtronic, INC. | $29.66 | 2023 | Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $29.27 | 2022-2023 | |
| Pharmacosmos Therapeutics INC. | $22.58 | 2025 | Monoferric |
| Mayne Pharma Commercial LLC | $19.22 | 2022 | |
| Scynexis, INC. | $16.66 | 2022 | |
| Avion Pharmaceuticals | $16.22 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $15.83 | 2021 | |
| Lilly USA, LLC | $15.65 | 2023 | Mounjaro |
| Davol INC. | $15.11 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.76 | 2023 | Seglentis, Livalo |
| Minerva Surgical, INC | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Gosch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.